Published on Monday March 17, 2014
Developing a polysaccharide pneumococcal vaccine
Smooth Drug Development is developing a pneumococcal vaccine.
Smooth Drug Development has already obtained relevant experience in vaccine studies.
Biosimilars are analogues of biopharmaceuticals with close molecule. Today biosimilar market is developing and it has great opportunities for future growth in the Russian Federation.
We provide a full spectrum of CRO solutions in performing phase I-IV clinical trials.
Smooth Drug Development is a reputed Contract Research Organization (CRO) performing clinical trials in Russia, CIS and Baltic States since 2011.